Tirzepatide Complete Research Guide: The GIP/GLP-1 Dual Agonist (2026) Tirzepatide (marketed as Mounjaro for type 2 diabetes and Zepbound for obesity) has become one of the most studied metabolic peptides in modern pharmaceutical research. As the first dual agonist targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, it represents a significant advancement […]
Author Archives: 汉普肽团队
Peptides for Anti-Aging: Complete Research Guide (2026) Aging research has entered an exciting era. As our understanding of the molecular mechanisms of aging deepens, peptides have emerged as one of the most studied classes of compounds for age-related research. This comprehensive guide examines the evidence behind the most investigated anti-aging peptides, their proposed mechanisms, research […]
Peptides for Athletic Performance: Complete Research Guide (2026) Athletes, coaches, and sports scientists are increasingly turning to research peptides as a focus of investigation into recovery, muscle growth, endurance, and injury rehabilitation. This comprehensive guide examines the evidence behind the most studied performance-related peptides, their proposed mechanisms, research findings, dosing protocols used in laboratory settings, […]
Peptide FAQ: 50 Most Common Questions About Research Peptides Answered (2026) Research peptides are a complex and often misunderstood topic. Whether you’re a researcher, student, or simply curious about peptides, you likely have many questions. This comprehensive FAQ guide answers the 50 most common questions about research peptides, covering topics such as what peptides are, […]
Growth Hormone Releasing Peptides Complete Guide: GHRPs, GHRH Analogs, Mechanisms & Research (2026) Growth hormone releasing peptides (GHRPs) and growth hormone releasing hormone (GHRH) analogs are a class of research peptides that stimulate the body’s natural production and release of growth hormone (GH). These peptides have been extensively studied for their potential applications in body […]
Peptide Safety and Side Effects Complete Guide: Risks, Management & Research Considerations (2026) Understanding the safety profile and potential side effects of research peptides is essential for responsible laboratory and preclinical research. While many peptides are generally well-tolerated at appropriate doses, all bioactive compounds carry potential risks, and improper use can lead to adverse effects. […]
Peptide Cycling and Stacking Complete Guide: Protocols, Combinations & Research Applications (2026) Peptide cycling and stacking are advanced research strategies that involve using multiple peptides in combination (stacking) and rotating them over time (cycling) to achieve synergistic effects, minimize tolerance, and optimize research outcomes. This comprehensive guide covers the principles of peptide cycling and stacking, […]
Semaglutide Complete Research Guide: GLP-1 Receptor Agonist (2026) Semaglutide has emerged as one of the most significant and widely researched peptides in the GLP-1 receptor agonist class, revolutionizing the fields of metabolic research, weight management, and cardiovascular health. Originally developed as a once-weekly injectable for type 2 diabetes management, semaglutide has since demonstrated profound effects […]
CJC-1295 + Ipamorelin Combination Complete Research Guide (2026) The combination of CJC-1295 (without DAC) and Ipamorelin has become one of the most widely researched and popular peptide protocols in the growth hormone-releasing peptide (GHRP) category. This synergistic combination targets two complementary pathways—growth hormone-releasing hormone (GHRH) receptor agonism and growth hormone secretagogue receptor (GHSR) agonism—to produce […]
Retatrutide Complete Research Guide: Triple GIP/GLP-1/Glucagon Agonist (2026) Retatrutide (LY3437943) represents the next frontier in metabolic peptide research—a first-in-class triple agonist targeting glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors simultaneously. Developed by Eli Lilly, retatrutide has demonstrated unprecedented weight loss efficacy in clinical trials, surpassing both semaglutide and tirzepatide. This comprehensive guide […]